Leuplin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE The standard dose of depot gonadotropin releasing hormone agonist (GnRHa) may be too much to prevent premature… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2007
2007
To reduce chemotherapy induced gonadotoxicity, co-treatment with gonadotropin releasing hormone against analogue (GnRHa) was… (More)
  • table 1
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2006
2006
OBJECTIVE To investigate the change in volume of uterine fibroids after GnRH analog (GnRHa) treatment. MATERIALS AND METHODS… (More)
Is this relevant?
2006
2006
Objective Recently, skin reactions to luteinizing hormone-releasing hormone (LH-RH) agonist therapy were reported after the 3… (More)
  • table 1
  • table 3
Is this relevant?
2004
2004
OBJECTIVES To clarify the relationship between calcitonin gene-related peptide (CGRP) and ovarian hormones (17beta-estradiol and… (More)
Is this relevant?
2003
2003
OBJECTIVES To assess the involvement of calcitonin gene-related peptide (CGRP) in the occurrence of hot flashes in men after… (More)
Is this relevant?
2003
2003
This study aimed to examine the activation of poly(ADP-ribose) polymerase (PARP) and the accumulation of its end product, poly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
GnRH agonist (GnRH-a) therapy is known to shrink uterine leiomyoma, although the molecular mechanisms responsible for this effect… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2002
2002
A randomized, multicenter, double-blind, parallel-group study was conducted in order to evaluate the hormonal kinetics… (More)
Is this relevant?
2001
2001
BACKGROUND/PURPOSE Twenty-two institutes have organized Keio University Prostate Cancer Study Group to study clinical efficacy… (More)
Is this relevant?